NLM Digital Collections

Search

Start Over Subjects Opioid-Related Disorders -- drug therapy ✖Remove constraint Subjects: Opioid-Related Disorders -- drug therapy Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

21. Opioid use disorder: developing depot buprenorphine products for treatment

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, February 2019
Subject(s):
Buprenorphine -- therapeutic use
Drug Development
Opioid-Related Disorders -- drug therapy
Buprenorphine -- administration & dosage
Clinical Trials as Topic
Delayed-Action Preparations
Narcotic Antagonists
Opiate Substitution Treatment
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

22. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States

23. MAT in the emergency department: FAQ

Author(s):
Newman, Sandra, author
Publication:
[Oakland, California] : California Health Care Foundation, March 2019
Subject(s):
Emergency Medical Services
Emergency Service, Hospital
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Substance-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Inservice Training
Methadone -- therapeutic use
State Government
Telemedicine
Humans
California
United States

24. MAT for hospitalized patients

Author(s):
Newman, Sandra, author
Publication:
[Oakland, California] : California Health Care Foundation, June 2019
Subject(s):
Hospitalization
Inpatients
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Drug Costs
Hospital Costs
Methadone -- therapeutic use
Reimbursement Mechanisms
State Government
Humans
California
United States

27. Buprenorphine: an overview for clinicians

Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States

28. Catalyzing Medicaid policy research with T-MSIS Analytic Files (TAF): learnings from year 1 of the Medicaid Data Learning Network (MDLN)

Author(s):
Gordon, Sarah, (Of Boston University), author
Johnson, Annaliese, author
Kennedy, Susan, (Of AcademyHealth), author
McConnel, John, (Of Oregon Health & Science University), author
Schpero, William, author
Publication:
Washington, DC : AcademyHealth, May 15, 2023
Subject(s):
Datasets as Topic
Health Policy
Health Services Research
Medicaid -- statistics & numerical data
Ethnicity
Fee-for-Service Plans
Health Expenditures
Information Storage and Retrieval
Managed Care Programs
Maternal Health
Opioid-Related Disorders -- drug therapy
Racial Groups
Reproductive Health
Utilization Review
United States

30. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States